Fredun Pharmaceuticals Limited
Fredun Pharmaceuticals Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: FREDUN and BSE: 539730 (ISIN INE194R01017).
It has a market capitalisation of ₹2,365 crore, a last close of ₹1,438 on 2026-10-19.
Valuation: a price-to-earnings ratio of 71.22x, a price-to-book ratio of 8.49x, a dividend yield of 0.0%.
Profitability: return on equity of 15.8%, return on capital employed of 34.4%, an operating margin of 14.1%.
Growth: sales growth of 32.2% a year over three years, net profit growth of 45.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.80x.
| Metric | Value |
|---|---|
| Market capitalisation | 2,365 |
| Last close | ₹1,438 |
| P/E (TTM) | 71.22x |
| P/B | 8.49x |
| Dividend yield | 0.0% |
| ROE (FY) | 15.8% |
| ROCE (FY) | 34.4% |
| Operating margin (TTM) | 14.1% |
| Sales growth, 3-year CAGR | 32.2% |
| Profit growth, 3-year CAGR | 45.4% |
| Debt / equity | 0.80x |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means